A group of experts who reviewed evidence on urinary tract infections (UTIs) failed to come up with many recommendations due ...

Despite the fact that sepsis causes an estimated 350,000 deaths in the U.S. each year, fewer than half of all Americans have ...

The FDA has approved Orlynvah, a new oral treatment for uncomplicated urinary tract infections (UTIs) in women who have limited options for effective antibiotic therapy.

The Food and Drug Administration has approved Iterum Therapeutics' Orlynvah, the first drug of its kind, which is designed to ...

Sodium-glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of cardiovascular and kidney outcomes in patients with ...

The U.S. Food and Drug Administration has approved Iterum Therapeutics' oral antibiotic to treat certain types of bacterial ...

For children with a history of recurrent urinary tract infection (RUTI), nitrofurantoin and cranberry products may reduce the ...

ORLYNVAH™ is the first oral penem approved for use in the U.S. and the second FDA-approved treatment for uUTIs in the past two decades--Company ...

The FDA granted Priority Review to gepotidacin for the treatment of female adults and adolescents with uncomplicated UTI.

Recurrent urinary tract infections affect kidney function in children with vesicoureteral reflux. Antibiotics can protect ...

U.S. Food and Drug Administration has approved Iterum Therapeutics' oral antibiotic to treat certain types of bacterial urinary tract infections (UTI) in adult women, the health regulator said Friday.